TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers

Published:2014-02-05 Issue:2 Volume:9 Page:e86824
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hägglöf Christina,Hammarsten Peter,Strömvall Kerstin,Egevad Lars,Josefsson Andreas,Stattin Pär,Granfors Torvald,Bergh Anders

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression;J St John;J Cancer Sci Ther,2012

2. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer;SA Tomlins;Science,2005

3. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer;SA Tomlins;Cancer Res,2006

4. Recurrent gene fusions in prostate cancer;C Kumar-Sinha;Nat Rev Cancer,2008

5. A causal role for ERG in neoplastic transformation of prostate epithelium;O Klezovitch;Proc Natl Acad Sci U S A,2008

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 Trials;European Urology Oncology;2024-07

2. Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer;Frontiers in Oncology;2024-03-22

3. Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:ERG Fusion Status in Prostate Cancer Using Whole Slide Images;Molecular Cancer Research;2024-01-29

4. Molecular biomarkers in prostate cancer;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

5. Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC);Clinical Genitourinary Cancer;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3